Generic submissions under review

How to access a list of generic drug submissions currently under review.

Consult the Drug and vaccine authorizations for COVID-19: List of applications received to access submissions under review that are related to the COVID-19 pandemic.

On this page

About the Generic Submissions Under Review (GSUR) list

The Generic Submissions Under Review (GSUR) List helps to make our review processes more transparent. The list will help Canadians understand if generic versions of brand name drugs are currently under review in Canada.

The GSUR List was announced as part of Phase III of the Submissions Under Review (SUR) List initiative. A Notice was published in 2024 announcing the expansion of the GSUR List.

The GSUR List includes abbreviated new drug submissions (ANDSs) accepted into review on or after October 1, 2018.

Finding information on the list

The GSUR List entries each include the:

  • medicinal ingredient(s)
  • therapeutic area populated with the World Health Organization Anatomical Therapeutic Chemical code
  • year and month the submission was accepted into review
  • company (sponsor) name for ANDSs accepted into review on or after April 1, 2024 only (for all other submissions, the information is listed as 'not available')

The list is updated monthly.

Decisions

Submissions are added to the GSUR List after they have been accepted into review. They remain on the GSUR list through interim negative decisions and various administrative and/or regulatory holds. For more information about the submission process and review targets, refer to the Management of Drug Submissions and Applications Guidance.

A submission is removed from the GSUR List when:

  • the submission is cancelled or
  • a final decision is made and the submission is no longer under review

You can see if a submission has been approved in the Notice of Compliance Database.

Health Canada announced in August 2018 that it will publish regulatory decision summaries for final positive and negative decisions for certain prescription generic drug submissions that might be of interest to stakeholders. These can be found using the Regulatory Decision Summary search tool in the Drug and Health Product Register.

Access to generic drugs

Many factors affect Canadians' access to generic drugs. For more information about generic drug products and submissions, please see the Fact Sheet on Access to Generic Drugs in Canada.

External consultations

Several external consultations have been held throughout the evolution of the SUR List initiative. In 2017, an external consultation was held on five transparency proposals for prescription drugs. This report provides a summary of the consultation results. An additional consultation was held in 2019 to assess the use of adding the company (sponsor) name to the GSUR List and the resulting impacts on stakeholders.

Other lists of submissions under review

The Submissions Under Review (SUR) Lists include new drug submissions and supplemental new drug submissions for new uses. Click here for details and to access the Drug and health products submissions under review lists.

Contact us

Questions can be sent to us by email: opprs.enquiries-enquetes.bprse@hc-sc.gc.ca.

View the list

You can view the generic submissions under review list any time.

This list is current as of: 2024-04-30.

An Excel version of the updated GSUR List is available.

Generic submissions currently under review: Abbreviated new drug submissions
Medicinal Ingredient(s) Therapeutic Area Year, Month Submission was Accepted into Review Company Name (available for submissions accepted into review on or after April 1, 2024)
Abacavir sulfate, dolutegravir sodium, lamivudine Antivirals for systemic use 2021-04 Not available
Abacavir sulfate, dolutegravir sodium, lamivudine Antivirals for systemic use 2023-03 Not available
Abiraterone acetate Endocrine therapy 2023-10 Not available
Acetaminophen Analgesics 2024-03 Not available
Acetaminophen, tramadol hydrochloride Analgesics 2023-02 Not available
Acyclovir Antivirals for systemic use 2022-01 Not available
Acyclovir Antivirals for systemic use 2023-05 Not available
Afatinib Antineoplastic agents 2020-03 Not available
Afatinib dimaleate Antineoplastic agents 2020-01 Not available
Afatinib dimaleate Antineoplastic agents 2019-12 Not available
Afatinib dimaleate Antineoplastic agents 2020-02 Not available
Alectinib hydrochloride Antineoplastic agents 2022-11 Not available
Alfacalcidol Vitamins 2023-08 Not available
Almotriptan malate Analgesics 2022-08 Not available
Amantadine hydrochloride Anti-parkinson drugs 2024-02 Not available
Ambrisentan Antihypertensives 2022-12 Not available
Amlodipine besylate, telmisartan Agents acting on the renin-angiotensin system 2022-12 Not available
Amphotericin B Antimycotics for systemic use 2022-02 Not available
Anastrozole Endocrine therapy 2022-11 Not available
Apixaban Antithrombotic agents 2023-06 Not available
Apremilast Immunosuppressants 2024-03 Not available
Aprepitant Antiemetics and antinauseants 2023-01 Not available
Aripiprazole Psycholeptics 2023-12 Not available
Aripiprazole Psycholeptics 2024-04 JAMP Pharma Corporation
Atenolol Beta blocking agents 2024-01 Not available
Atomoxetine hydrochloride Psychoanaleptics 2024-02 Not available
Atovaquone Antiprotozoals 2023-04 Not available
Atovaquone Antiprotozoals 2023-09 Not available
Axitinib Antineoplastic agents 2024-02 Not available
Azacitidine Antineoplastic agents 2024-04 MSN Labs Canada Inc.
Azilsartan medoxomil Agents acting on the renin-angiotensin system 2022-03 Not available
Baclofen Muscle relaxants 2023-05 Not available
Bilastine Antihistamines for systemic use 2022-08 Not available
Bilastine Antihistamines for systemic use 2022-06 Not available
Bilastine Antihistamines for systemic use 2022-08 Not available
Bilastine Antihistamines for systemic use 2022-06 Not available
Bilastine Antihistamines for systemic use 2023-09 Not available
Bilastine Antihistamines for systemic use 2023-10 Not available
Bilastine Antihistamines for systemic use 2023-12 Not available
Bilastine Antihistamines for systemic use 2024-02 Not available
Bimatoprost Ophthalmologicals 2022-02 Not available
Bimatoprost Ophthalmologicals 2023-06 Not available
Bimatoprost Ophthalmologicals 2023-07 Not available
Bortezomib Antineoplastic agents 2023-07 Not available
Bortezomib mannitol boronic ester Antineoplastic agents 2023-11 Not available
Brexpiprazole Psycholeptics 2023-04 Not available
Brexpiprazole Psycholeptics 2023-04 Not available
Brexpiprazole Psycholeptics 2023-04 Not available
Brexpiprazole Psycholeptics 2023-04 Not available
Brexpiprazole Psycholeptics 2023-05 Not available
Brexpiprazole Psycholeptics 2023-05 Not available
Brimonidine tartrate Ophthalmologicals 2023-04 Not available
Brimonidine tartrate, timolol maleate Ophthalmologicals 2023-07 Not available
Brivaracetam Antiepileptics 2022-05 Not available
Brivaracetam Antiepileptics 2022-05 Not available
Brivaracetam Antiepileptics 2023-11 Not available
Bromfenac sodium sesquihydrate Ophthalmologicals 2022-06 Not available
Buffer solution, melphalan hydrochloride Antineoplastic agents 2022-02 Not available
Bupivacaine hydrochloride Anesthetics 2024-02 Not available
Buprenorphine Analgesics 2022-05 Not available
Buprenorphine Analgesics 2024-01 Not available
Bupropion hydrochloride Psychoanaleptics 2021-07 Not available
Bupropion hydrochloride Psychoanaleptics 2023-04 Not available
Buspirone hydrochloride Psycholeptics 2023-09 Not available
Cabazitaxel Antineoplastic agents 2022-08 Not available
Cabazitaxel Antineoplastic agents 2024-01 Not available
Cabergoline Other gynecologicals 2023-10 Not available
Calcitrol Vitamins 2023-05 Not available
Canagliflozin Drugs used in diabetes 2020-07 Not available
Canagliflozin Drugs used in diabetes 2020-07 Not available
Canagliflozin Drugs used in diabetes 2023-03 Not available
Canagliflozin Drugs used in diabetes 2023-12 Not available
Canagliflozin Drugs used in diabetes 2024-04 Apotex Inc
Carbidopa, levodopa Anti-Parkinson drugs 2023-09 Not available
Carbidopa, levodopa Anti-Parkinson drugs 2023-12 Not available
Carfilzomib Antineoplastic agents 2022-05 Not available
Carfilzomib Antineoplastic agents 2022-03 Not available
Carfilzomib Antineoplastic agents 2022-06 Not available
Carfilzomib Antineoplastic agents 2022-09 Not available
Carfilzomib Antineoplastic agents 2023-06 Not available
Cefixime Antibacterials for systemic use 2023-09 Not available
Cefixime Antibacterials for systemic use 2023-10 Not available
Cefixime Antibacterials for systemic use 2024-01 Not available
Celecoxib Antiinflammatory and antirheumatic products 2019-04 Not available
Ciclopirox Antifungals for dermatological use 2023-04 Not available
Cisatracurium besylate Muscle relaxants 2024-02 Not available
Cladribine Immunosuppressants 2023-05 Not available
Cladribine Immunosuppressants 2024-01 Not available
Clopidogrel bisulfate Antithrombotic agents 2023-03 Not available
Clozapine Psycholeptics 2021-11 Not available
Cobicistat, elvitegravir, emtricitabine, tenofovir alafenamide Antivirals for systemic use 2023-09 Not available
Colesevelam hydrochloride Lipid modifying agents 2021-05 Not available
Cyclophosphamide Antineoplastic agents 2022-12 Not available
Cyclophosphamide Antineoplastic agents 2023-10 Not available
Cyclophosphamide Antineoplastic agents 2023-11 Not available
Cyclophosphamide Antineoplastic agents 2024-01 Not available
Cyclophosphamide monohydrate Antineoplastic agents 2024-04 Formative Pharma Inc.
Dapagliflozin Drugs used in diabetes 2023-10 Not available
Dasatinib Antineoplastic agents 2022-05 Not available
Dasatinib Antineoplastic agents 2023-10 Not available
Deferasirox All other therapeutic products 2021-08 Not available
Deferasirox All other therapeutic products 2021-11 Not available
Degarelix acetate Endocrine therapy 2024-01 Not available
Desmopressin acetate Pituitary and hypothalamic hormones and analogues 2022-05 Not available
Desmopressin acetate Pituitary and hypothalamic hormones and analogues 2023-02 Not available
Desmopressin acetate Pituitary and hypothalamic hormones and analogues 2023-10 Not available
Desvenlafaxine succinate Psychoanaleptics 2024-04 Mint Pharmaceuticals Inc
Dexmedetomidine Psycholeptics 2024-02 Not available
Dexmedetomidine hydrochloride Psycholeptics 2022-08 Not available
Dexmedetomidine hydrochloride Psycholeptics 2022-09 Not available
Dexmedetomidine hydrochloride Psycholeptics 2024-01 Not available
Diclofenac potassium Antiinflammatory and antirheumatic products 2024-02 Not available
Dienogest Sex hormones and modulators of the genital system 2024-03 Not available
Diltiazem hydrochloride Calcium channel blockers 2024-02 Not available
Divalproex sodium Antiepileptics 2020-12 Not available
Dobutamine hydrochloride Cardiac therapy 2024-03 Not available
Dolutegravir Antivirals for systemic use 2020-01 Not available
Dolutegravir sodium Antivirals for systemic use 2023-09 Not available
Donepezil hydrochloride monohydrate Psychoanaleptics 2023-08 Not available
Doxepin hydrochloride Psychoanaleptics 2023-12 Not available
Doxepin hydrochloride Psychoanaleptics 2023-08 Not available
Doxepin hydrochloride Psychoanaleptics 2021-02 Not available
Doxycycline hyclate Antibacterials for systemic use 2023-05 Not available
Doxycycline monohydrate Antibacterials for systemic use 2022-12 Not available
Doxylamine succinate, pyridoxine hydrochloride Antihistamines for systemic use 2023-09 Not available
Edoxaban tosylate Antithrombotic agents 2023-08 Not available
Edoxaban tosylate Antithrombotic agents 2024-02 Not available
Efinaconazole Antifungals for dermatological use 2019-11 Not available
Efinaconazole Antifungals for dermatological use 2020-01 Not available
Efinaconazole Antifungals for dermatological use 2020-02 Not available
Efinaconazole Antifungals for dermatological use 2020-11 Not available
Efinaconazole Antifungals for dermatological use 2020-12 Not available
Efinaconazole Antifungals for dermatological use 2021-04 Not available
Efinaconazole Antifungals for dermatological use 2022-03 Not available
Efinaconazole Antifungals for dermatological use 2022-06 Not available
Efinaconazole Antifungals for dermatological use 2023-05 Not available
Eltrombopag olamine Antihemorrhagics 2023-09 Not available
Eltrombopag olamine Antihemorrhagics 2023-12 Not available
Eltrombopag olamine Antihemorrhagics 2024-02 Not available
Eltrombopag olamine Antihemorrhagics 2024-04 Dr Reddys Laboratories Ltd
Empagliflozin Drugs used in diabetes 2021-10 Not available
Empagliflozin Drugs used in diabetes 2021-11 Not available
Empagliflozin Drugs used in diabetes 2021-09 Not available
Empagliflozin Drugs used in diabetes 2021-12 Not available
Empagliflozin Drugs used in diabetes 2022-09 Not available
Empagliflozin Drugs used in diabetes 2022-09 Not available
Empagliflozin Drugs used in diabetes 2023-04 Not available
Empagliflozin Drugs used in diabetes 2023-05 Not available
Empagliflozin Drugs used in diabetes 2023-12 Not available
Empagliflozin Drugs used in diabetes 2024-02 Not available
Empagliflozin, metformin hydrochloride Drugs used in diabetes 2021-10 Not available
Emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide hemifumarate Antivirals for systemic use 2022-04 Not available
Emtricitabine, tenofovir alafenamide Antivirals for systemic use 2022-01 Not available
Emtricitabine, tenofovir alafenamide fumarate Antivirals for systemic use 2022-04 Not available
Emtricitabine, tenofovir alafenamide hemifumarate Antivirals for systemic use 2022-04 Not available
Emtricitabine, tenofovir alafenamide hemifumarate Antivirals for systemic use 2022-07 Not available
Enzalutamide Endocrine therapy 2019-06 Not available
Enzalutamide Endocrine therapy 2020-10 Not available
Enzalutamide Endocrine therapy 2022-04 Not available
Eplerenone Diuretics 2023-07 Not available
Eribulin meslyate Antineoplastic agents 2023-05 Not available
Eribulin meslyate Antineoplastic agents 2023-07 Not available
Eribulin meslyate Antineoplastic agents 2023-12 Not available
Ertapenem sodium Antibacterials for systemic use 2022-07 Not available
Eslicarbazepine acetate Antiepileptics 2021-10 Not available
Eslicarbazepine acetate Antiepileptics 2022-11 Not available
Esomeprazole magnesium trihydrate Drugs for acid related disorders 2023-06 Not available
Esomeprazole magnesium trihydrate, naproxen Antiinflammatory and antirheumatic products 2023-12 Not available
Estradiol Sex hormones and modulators of the genital system 2023-05 Not available
Eszopiclone Psycholeptics 2023-05 Not available
Ethinyl estradiol, etonogestrel Other gynecologicals 2021-08 Not available
Ethinyl estradiol, etonogestrel Other gynecologicals 2024-01 Not available
Etoposide Antineoplastic agents 2022-12 Not available
Fenofibrate Lipid modifying agents 2022-05 Not available
Fenofibrate Lipid modifying agents 2024-01 Not available
Fesoterodine fumarate Urologicals 2024-01 Not available
Finasteride Other dermatological preparations 2023-05 Not available
Fingolimod hydrochloride Immunosuppressants 2019-06 Not available
Fluconazole Antimycotics for systemic use 2023-05 Not available
Fludrocortisone 21-acetate Corticosteroids for systemic use 2023-02 Not available
Fluoxetine hydrochloride Psychoanaleptics 2023-02 Not available
Fosaprepitant dimeglumine Antiemetics and antinauseants 2022-10 Not available
Fosfomycin Antibacterials for systemic use 2023-08 Not available
Fulvestrant Endocrine therapy 2024-03 Not available
Gabapentin Analgesics 2023-12 Not available
Galantamine hydrobromide Psychoanaleptics 2023-08 Not available
Ganirelix acetate Pituitary and hypothalamic hormones and analogues 2024-02 Not available
Gemcitabine hydrochloride Antineoplastic agents 2022-05 Not available
Gemcitabine hydrochloride Antineoplastic agents 2023-05 Not available
Glatiramer acetate Immunostimulants 2020-11 Not available
Glycopyrronium bromide Drugs for obstructive airway diseases 2024-01 Not available
Granisetron hydrochloride Antiemetics and antinauseants 2023-02 Not available
Guanfacine hydrochloride Antihypertensives 2023-09 Not available
Guanfacine hydrochloride Antihypertensives 2023-09 Not available
Haloperidol decanoate Psycholeptics 2023-03 Not available
Hydrochlorothiazide, quinapril hydrochloride Agents acting on the renin-angiotensin system 2022-04 Not available
Hydromorphone hydrochloride Analgesics 2022-09 Not available
Hydromorphone hydrochloride Analgesics 2024-04 Pharmascience Inc
Hydroxychloroquine sulfate Antiprotozoals 2023-06 Not available
Hydroxyurea Antineoplastic agents 2023-06 Not available
Hyoscine butylbromide Drugs for functional gastrointestinal disorders 2023-03 Not available
Hyoscine butylbromide Drugs for functional gastrointestinal disorders 2023-05 Not available
Ibrutinib Antineoplastic agents 2021-05 Not available
Ibrutinib Antineoplastic agents 2021-01 Not available
Ibrutinib Antineoplastic agents 2021-06 Not available
Ibrutinib Antineoplastic agents 2022-11 Not available
Icatibant acetate Other hematological agents 2023-07 Not available
Indapamide Diuretics 2023-05 Not available
Indapamide, perindopril erbumine Agents acting on the renin-angiotensin system 2022-05 Not available
Iodixanol Contrast media 2024-02 Not available
Iron (III)-hydroxide sucrose complex Antianemic preparations 2024-01 Not available
Isosorbide-5-monohydrate Cardiac therapy 2024-01 Not available
Ketamine hydrochloride Anesthetics 2022-02 Not available
Ketoconazole Antimycotics for systemic use 2023-05 Not available
Lacosamide Antiepileptics 2023-01 Not available
Lamotrigine Antiepileptics 2023-10 Not available
Lanreotide acetate Pituitary and hypothalamic hormones and analogues 2023-07 Not available
Lansoprazole Drugs for acid related disorders 2023-11 Not available
Latanoprost, timolol maleate Ophthalmologicals 2021-12 Not available
Leflunomide Immunosuppressants 2023-08 Not available
Leflunomide Immunosuppressants 2024-03 Not available
Lenalidomide Immunosuppressants 2022-09 Not available
Letermovir Antivirals for systemic use 2024-02 Not available
Leucovorin calcium All other therapeutic products 2023-04 Not available
Leucovorin calcium All other therapeutic products 2023-11 Not available
Leucovorin calcium All other therapeutic products 2023-11 Not available
Levetiracetam Antiepileptics 2021-10 Not available
Levetiracetam Antiepileptics 2023-01 Not available
Levetiracetam Antiepileptics 2023-01 Not available
Levetiracetam Antiepileptics 2023-02 Not available
Levetiracetam Antiepileptics 2023-10 Not available
Levetiracetam Antiepileptics 2024-01 Not available
Levetiracetam Antiepileptics 2024-04 Marcan Pharmaceuticals Inc
Levocabastine Other alimentary tract and metabolism products 2023-12 Not available
Levothyroxine sodium Thyroid therapy 2023-02 Not available
Levothyroxine sodium Thyroid therapy 2023-11 Not available
Levothyroxine sodium Thyroid therapy 2024-04 Genix Pharmaceuticals Corporation
Lidocaine, prilocaine Antipruritics, including antihistamines, anesthetics, etc. 2022-02 Not available
Linagliptin Drugs used in diabetes 2020-01 Not available
Linagliptin Drugs used in diabetes 2020-10 Not available
Linagliptin Drugs used in diabetes 2021-09 Not available
Linagliptin Drugs used in diabetes 2022-05 Not available
Linagliptin Drugs used in diabetes 2022-05 Not available
Linagliptin Drugs used in diabetes 2023-01 Not available
Linagliptin Drugs used in diabetes 2023-06 Not available
Linagliptin Drugs used in diabetes 2023-08 Not available
Linagliptin Drugs used in diabetes 2023-10 Not available
Linagliptin, metformin hydrochloride Drugs used in diabetes 2021-10 Not available
Linagliptin, metformin hydrochloride Drugs used in diabetes 2023-09 Not available
Linagliptin, metformin hydrochloride Drugs used in diabetes 2024-01 Not available
Liothyronine sodium Thyroid therapy 2023-05 Not available
Liothyronine sodium Thyroid therapy 2023-05 Not available
Liraglutide Drugs used in diabetes 2023-11 Not available
Liraglutide Drugs used in diabetes 2024-04 Dr Reddys Laboratories Ltd
Lisdexamfetamine dimesylate Psychoanaleptics 2021-07 Not available
Lisdexamfetamine dimesylate Psychoanaleptics 2021-08 Not available
Lisdexamfetamine dimesylate Psychoanaleptics 2021-11 Not available
Lisdexamfetamine dimesylate Psychoanaleptics 2022-06 Not available
Lisdexamfetamine dimesylate Psychoanaleptics 2022-11 Not available
Lisdexamfetamine dimesylate Psychoanaleptics 2022-12 Not available
Lisdexamfetamine dimesylate Psychoanaleptics 2023-09 Not available
Lorazepam Psycholeptics 2023-03 Not available
Lurasidone hydrochloride Psycholeptics 2020-03 Not available
Macitentan Antihypertensives 2020-01 Not available
Macitentan Antihypertensives 2020-02 Not available
Macitentan Antihypertensives 2020-06 Not available
Macitentan Antihypertensives 2021-11 Not available
Macitentan Antihypertensives 2022-01 Not available
Macitentan Antihypertensives 2021-12 Not available
Melphalan hydrochloride Antineoplastic agents 2024-03 Not available
Mesalazine Antidiarrheals, intestinal anti-inflammatory/anti-infective agents 2022-05 Not available
Metformin hydrochloride Drugs used in diabetes 2024-02 Not available
Metformin hydrochloride Drugs used in diabetes 2024-03 Not available
Metformin hydrochloride, sitagliptin Drugs used in diabetes 2022-05 Not available
Metformin hydrochloride, sitagliptin Drugs used in diabetes 2023-02 Not available
Metformin hydrochloride, sitagliptin phosphate monohydrate Drugs used in diabetes 2022-12 Not available
Metformin hydrochloride, sitagliptin phosphate monohydrate Drugs used in diabetes 2024-01 Not available
Methadone hydrochloride Other nervous system drugs 2021-07 Not available
Methotrexate Antineoplastic agents 2022-12 Not available
Methotrexate Antineoplastic agents 2023-04 Not available
Methotrexate Antineoplastic agents 2023-07 Not available
Methotrexate disodium Antineoplastic agents 2023-07 Not available
Methotrexate disodium Antineoplastic agents 2024-02 Not available
Methylphenidate hydrochloride Psychoanaleptics 2022-03 Not available
Methylprednisolone sodium succinate Corticosteroids for systemic use 2023-10 Not available
Metoclopramide hydrochloride Drugs for functional gastrointestinal disorders 2022-12 Not available
Metronidazole Antibacterials for systemic use 2024-01 Not available
Micafungin sodium Antimycotics for systemic use 2023-02 Not available
Mirabegron Urologicals 2022-09 Not available
Mirabegron Urologicals 2023-07 Not available
Mirtazapine Psychoanaleptics 2023-10 Not available
Moxifloxacin hydrochloride Antibacterials for systemic use 2023-11 Not available
Moxifloxacin hydrochloride Ophthalmologicals 2023-07 Not available
Mycophenolate mofetil Immunosuppressants 2023-02 Not available
Nadolol Beta blocking agents 2021-11 Not available
Naloxegol Drugs for constipation 2021-08 Not available
Naloxone hydrochloride All other therapeutic products 2023-02 Not available
Naloxone hydrochloride All other therapeutic products 2023-11 Not available
Naloxone hydrochloride dihydrate All other therapeutic products 2022-10 Not available
Naloxone hydrochloride dihydrate All other therapeutic products 2024-01 Not available
Naltrexone hydrochloride Other nervous system drugs 2023-11 Not available
Naratriptan hydrochloride Analgesics 2023-07 Not available
Nebivolol hydrochloride Beta blocking agents 2022-06 Not available
Nelarabine Antineoplastic agents 2022-08 Not available
Nifedipine Calcium channel blockers 2023-05 Not available
Nifedipine Calcium channel blockers 2023-06 Not available
Nilotinib hydrochloride Antineoplastic agents 2024-02 Not available
Nilotinib hydrochloride monohydrate Antineoplastic agents 2023-01 Not available
Nilotinib hydrochloride monohydrate Antineoplastic agents 2023-07 Not available
Nintedanib Antineoplastic agents 2021-10 Not available
Nintedanib esylate Antineoplastic agents 2023-06 Not available
Nortriptyline hydrochloride Psychoanaleptics 2022-11 Not available
Nortriptyline hydrochloride Psychoanaleptics 2023-05 Not available
Octreotide acetate Pituitary and hypothalamic hormones and analogues 2024-04 Sterimax Inc
Olopatadine hydrochloride Ophthalmologicals 2023-08 Not available
Olopatadine hydrochloride Ophthalmologicals 2022-03 Not available
Olopatadine hydrochloride Ophthalmologicals 2023-05 Not available
Ondansetron hydrochloride Antiemetics and antinauseants 2024-02 Not available
Oxybutynin chloride Urologicals 2023-05 Not available
Palbociclib Antineoplastic agents 2022-12 Not available
Palbociclib Antineoplastic agents 2023-01 Not available
Palbociclib Antineoplastic agents 2023-05 Not available
Palbociclib Antineoplastic agents 2023-11 Not available
Palbociclib Antineoplastic agents 2023-11 Not available
Paliperidone Psycholeptics 2020-09 Not available
Paliperidone Psycholeptics 2024-01 Not available
Paliperidone palmitate Psycholeptics 2020-09 Not available
Paliperidone palmitate Psycholeptics 2020-11 Not available
Paliperidone palmitate Psycholeptics 2021-06 Not available
Pamidronate disodium Drugs for treatment of bone diseases 2023-10 Not available
Pantoprazole magnesium Drugs for acid related disorders 2024-01 Not available
Pazopanib hydrochloride Antineoplastic agents 2022-10 Not available
Pemetrexed disodium Antineoplastic agents 2024-02 Not available
Piperacillin sodium, tazobactam sodium Antibacterials for systemic use 2022-08 Not available
Pirfenidone Immunosuppressants 2023-02 Not available
Pomalidomide Immunosuppressants 2021-03 Not available
Posaconazole Antimycotics for systemic use 2022-12 Not available
Pravastatin sodium Lipid modifying agents 2023-05 Not available
Pregabalin Analgesics 2023-11 Not available
Progesterone Sex hormones and modulators of the genital system 2023-12 Not available
Propranolol hydrochloride Beta blocking agents 2022-11 Not available
Propranolol hydrochloride Beta blocking agents 2023-04 Not available
Prucalopride succinate Drugs for constipation 2022-03 Not available
Quinapril Agents acting on the renin-angiotensin system 2022-05 Not available
Regorafenib Antineoplastic agents 2022-04 Not available
Ribociclib succinate Antineoplastic agents 2024-04 Natco Pharma (Canada) Inc
Rivaroxaban Antithrombotic agents 2022-11 Not available
Rivaroxaban Antithrombotic agents 2023-01 Not available
Rivaroxaban Antithrombotic agents 2023-03 Not available
Rivaroxaban Antithrombotic agents 2023-05 Not available
Rivaroxaban Antithrombotic agents 2023-07 Not available
Rivastigmine hydrogen tartrate Psychoanaleptics 2022-05 Not available
Rupatadine fumarate Antihistamines for systemic use 2022-09 Not available
Rupatadine fumarate Antihistamines for systemic use 2024-04 Pharmascience Inc
Ruxolitinib phosphate Antineoplastic agents 2023-04 Not available
Sacubitril, valsartan Agents acting on the renin-angiotensin system 2022-01 Not available
Sacubitril, valsartan Agents acting on the renin-angiotensin system 2023-01 Not available
Sapropterin dihydrochloride Other alimentary tract and metabolism products 2022-10 Not available
Sapropterin dihydrochloride Other alimentary tract and metabolism products 2023-10 Not available
Saxagliptin Drugs used in diabetes 2024-01 Not available
Saxagliptin hydrochloride Drugs used in diabetes 2023-09 Not available
Selexipag Antithrombotic agents 2022-08 Not available
Semaglutide Drugs used in diabetes 2024-02 Not available
Semaglutide Drugs used in diabetes 2024-03 Not available
Sevelamer carbonate All other therapeutic products 2022-04 Not available
Sevelamer hydrochloride All other therapeutic products 2023-08 Not available
Sildenafil citrate Antihypertensives 2023-07 Not available
Sitagliptin Drugs used in diabetes 2022-04 Not available
Sitagliptin phosphate Drugs used in diabetes 2022-09 Not available
Sitagliptin phosphate Drugs used in diabetes 2023-05 Not available
Sitagliptin phosphate monohydrate Drugs used in diabetes 2023-05 Not available
Sitagliptin phosphate monohydrate Drugs used in diabetes 2023-09 Not available
Sodium valproate Antiepileptics 2022-02 Not available
Spironolactone Diuretics 2024-03 Not available
Sugammadex sodium All other therapeutic products 2022-03 Not available
Sugammadex sodium All other therapeutic products 2022-07 Not available
Sugammadex sodium All other therapeutic products 2022-08 Not available
Sugammadex sodium All other therapeutic products 2022-04 Not available
Sugammadex sodium All other therapeutic products 2022-06 Not available
Sugammadex sodium All other therapeutic products 2022-05 Not available
Sugammadex sodium All other therapeutic products 2023-02 Not available
Sugammadex sodium All other therapeutic products 2023-04 Not available
Sugammadex sodium All other therapeutic products 2023-07 Not available
Sugammadex sodium All other therapeutic products 2023-08 Not available
Sugammadex sodium All other therapeutic products 2023-09 Not available
Sugammadex sodium All other therapeutic products 2023-10 Not available
Sugammadex sodium All other therapeutic products 2023-12 Not available
Sunitinib malate Antineoplastic agents 2023-11 Not available
Tacrolimus Immunosuppressants 2023-10 Not available
Tacrolimus Other dermatological preparations 2021-03 Not available
Tadalafil Urologicals 2023-12 Not available
Tadalafil Urologicals 2024-01 Not available
Tamsulosin hydrochloride Urologicals 2024-02 Not available
Tenofovir alafenamide fumarate Antivirals for systemic use 2022-01 Not available
Tenofovir alafenamide fumarate Antivirals for systemic use 2022-01 Not available
Tenofovir alafenamide fumarate Antivirals for systemic use 2022-07 Not available
Terbinafine hydrochloride Antifungals for dermatological use 2022-07 Not available
Terbinafine hydrochloride Antifungals for dermatological use 2022-04 Not available
Teriflunomide Immunosuppresants 2024-04 Accel Pharma Inc
Teriparatide acetate Calcium homeostasis 2023-09 Not available
Testosterone enanthate Sex hormones and modulators of the genital system 2023-05 Not available
Ticagrelor Antithrombotic agents 2023-09 Not available
Ticagrelor Antithrombotic agents 2024-02 Not available
Timolol maleate Ophthalmologicals 2022-07 Not available
Timolol maleate, travoprost Ophthalmologicals 2023-05 Not available
Tiotropium bromide monohydrate Drugs for obstructive airway diseases 2023-01 Not available
Tipiracil hydrochloride, trifluridine Antineoplastic agents 2024-03 Not available
Tobramycin Antibacterials for systemic use 2022-12 Not available
Tobramycin Antibacterials for systemic use 2023-10 Not available
Tofacitinib citrate Immunosuppressants 2023-09 Not available
Tofacitinib citrate Immunosuppressants 2023-10 Not available
Tofacitinib citrate Immunosuppressants 2024-02 Not available
Tolvaptan Diuretics 2023-11 Not available
Trabectedin Antineoplastic agents 2021-04 Not available
Tranexamic acid Antihemorrhagics 2023-04 Not available
Travoprost Ophthalmologicals 2022-06 Not available
Travoprost Ophthalmologicals 2023-04 Not available
Treosulfan Antineoplastic agents 2023-06 Not available
Vancomycin hydrochloride Antibacterials for systemic use 2022-03 Not available
Varenicline tartrate Other nervous system drugs 2024-02 Not available
Vilazodone hydrochloride Psychoanaleptics 2023-06 Not available
Zopiclone Psycholeptics 2023-04 Not available
Zopiclone Psycholeptics 2023-11 Not available

Page details

Date modified: